富禾生醫股份有限公司 Approved
最後更新時間 2025/07/18 , 07:14 AM
最後更新時間 2025/07/18 , 07:14 AM
負責人
Zhao,Yi
統一編號
54151258
成立日期
2012/12/24
資本額
NT$600,000,000
實收資本額
NT$399,112,090
股票代號
7773
電話
02-29953838
地址
10F, No. 10, Ln. 609, Sec. 5, Chongsin Rd., Sanchong Dist., New Taipei City, 241, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Zhao,Yi Chairman 5.26% YI LI YA DEVELOPMENT CO., LTD.
Li,Jian-Mou Director 3.61%
Qiu,Quan-Cheng Director 2.03%
TA YA INNOVATION INVESTMENT CO., LTD. Director 6.45%
Liu,Jian-Neng Director 2.51%
Hou,Bo-Qiang Director 0.38%
Chen,Yi-Fang Independent Director 0.00%
Lin,Qing-Bo Independent Director 0.00%
Gao,Hong-Ming Independent Director 0.00%
營業項目
  • Other Technical Testing and Analysis(712999)
  • Manufacture of Medicinal Chemical Products(200599)
  • 公司歷程
  • Change Capital to 600,000,000
    2023/07/06
  • Change Person in Charge to Zhao,Yi
    2023/07/06
  • Change Person in Charge to Zhao,En-De
    2017/11/23
  • Change Person in Charge to Shen,Qiu-Lin
    2017/02/08
  • Change Person in Charge to Chen,Huang-Rong
    2014/12/29
  • Change Capital to 300,000,000
    2014/11/03
  • Change Capital to 59,000,000
    2013/04/01
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023
    Operating income 7,685 24,713
    Operating cost 3,275 11,792
    Profit (loss) of initial recognition of biological asset and agricultural products - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - -
    Operating gross profit (loss) 4,410 12,921
    Unrealized profit (loss) on sales of goods - -
    Realized profit (loss) on sales of goods - -
    Operating gross profit (loss), net 4,410 12,921
    Operating expenses 32,295 56,788
    Other gain (loss), net - -
    Operating profit (loss) -27,885 -43,867
    Non-operating income and expenses 4,188 2,127
    Net profit (loss) before tax -23,697 -41,740
    Income tax expense (benefits) - -
    Net profit (loss) of ongoing business for the current period -23,697 -41,740
    Profit (loss) of closed units - -
    Profit (loss) of non-jointly controlled equity before merger - -
    Net profit (loss) for the current period -23,697 -41,740
    Other comprehensive profit (loss), net - -
    Comprehensive net profit and loss of non-jointly controlled equity before merger - -
    Total comprehensive profit and loss for the current period -23,697 -41,740
    Net profit (loss) attributable to owners of parent company - -
    Net profit (loss) form equity attributable to former owner of business combination under common control - -
    Net profit (loss) attributable to non-controlling interests - -
    Comprehensive profit (loss) attributable to owners of parent company - -
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - -
    Comprehensive profit (loss) attributable to non-controlling interests - -
    Basic earnings per share (yuan) 0 -1
    項目 2024 2023
    Net cash inflow (outflow) from operating activities - -
    Net cash inflows (outflows) from investing activities - -
    Net cash inflow (outflow) from financing activities - -
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - -
    Increase (decrease) in cash and cash equivalents in the current period - -
    Beginning balance of cash and cash equivalents - -
    Ending balance of cash and cash equivalents - -
    項目 2024 2023
    Current asset 549,512 590,009
    Non-current asset 27,723 14,115
    Total asset 577,235 604,124
    Current liability 11,207 15,355
    Non-current liability 438 37
    Total liability 11,645 15,392
    share capital 387,112 387,112
    Equity - secruity token - -
    capital reserve 202,175 438,223
    retained earning -23,697 -236,603
    Other equity - -
    Treasury stock - -
    Total equity attributable to owners of parent company - -
    Equity attributable to former owner of business combination under common control - -
    Equity attributable to non-controlling interest before business merger under common control - -
    Non-controlling interests - -
    Total Equity 565,590 588,732
    Share capital awaiting retirement (unit: share) 0 0
    Issued shares of advance equity (unit: shares) 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0
    Net asset value per share 14 15
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • PHYDUXON
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Compensation for damage
    2018
  • Violation of trade secret Law, etc.
    2018
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。